[
  {
    "ts": null,
    "headline": "Why Is Johnson & Johnson (JNJ) Up 7.2% Since Last Earnings Report?",
    "summary": "Johnson & Johnson (JNJ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "url": "https://finnhub.io/api/news?id=a88afcaae9e9548deddfce6bf03bba6cfded4b4097274d2fb21ac2b1b8d43fc4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755271803,
      "headline": "Why Is Johnson & Johnson (JNJ) Up 7.2% Since Last Earnings Report?",
      "id": 136376184,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (JNJ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
      "url": "https://finnhub.io/api/news?id=a88afcaae9e9548deddfce6bf03bba6cfded4b4097274d2fb21ac2b1b8d43fc4"
    }
  },
  {
    "ts": null,
    "headline": "Kenvue attracts share purchase by activist investor Sachem Head",
    "summary": "NEW YORK (Reuters) -Band-Aid and Tylenol maker Kenvue attracted the attention of another activist investor in the second quarter, with Sachem Head Capital Management reporting that it bought into the stock.  Sachem, run by Scott Ferguson, said in a regulatory filing on Thursday that it owned 10.6 million shares in the consumer healthcare company on June 30.  According to the filing, Kenvue was the firm's fourth biggest holding at the end of the quarter after Twilio, Talen Energy and Seagate Technology Holdings.",
    "url": "https://finnhub.io/api/news?id=c49a7ab32557bb6a25ca5638d5cd779b4ab65da5e25a6bae6440a19cf83cf1d1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755216771,
      "headline": "Kenvue attracts share purchase by activist investor Sachem Head",
      "id": 136367964,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "NEW YORK (Reuters) -Band-Aid and Tylenol maker Kenvue attracted the attention of another activist investor in the second quarter, with Sachem Head Capital Management reporting that it bought into the stock.  Sachem, run by Scott Ferguson, said in a regulatory filing on Thursday that it owned 10.6 million shares in the consumer healthcare company on June 30.  According to the filing, Kenvue was the firm's fourth biggest holding at the end of the quarter after Twilio, Talen Energy and Seagate Technology Holdings.",
      "url": "https://finnhub.io/api/news?id=c49a7ab32557bb6a25ca5638d5cd779b4ab65da5e25a6bae6440a19cf83cf1d1"
    }
  }
]